Announced Tue, 7 Jul · 10:43 IST
Routine RTA Compliance Certificate for Q1 FY2027 Dematerialisation
Compliance View source PDF
BETA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-6.8%1-day move
₹2134.90
prior close
₹2087.10
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.3-0.5—-0.8-6.8+2.7+10.7+9.6+8.0+5.5————
Up moveDown movePending
AI summary
RTA MUFG Intime India has submitted a SEBI Regulation 74(5) compliance certificate to Beta Drugs confirming that securities received for dematerialisation during Q1 FY27 (quarter ended 30 June 2026) were processed and listed on stock exchanges. Mutilated certificates were cancelled after verification and depository names were updated in the register of members within required timelines.
Likely market impact
Routine regulatory compliance filing with no material impact on business fundamentals or stock price. Standard RTA confirmation of demat request processing.